Point-Of-Care Testing (POCT) Market size, Share, Growth, and Industry Analysis, By Type (Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Urinalysis Testing, Others) By Application (Hospitals, Clinic, Laboratory, Others), and Regional Insights and Forecast to 2034

• 

  Request a Free sample to learn more about this report

POINT-OF-CARE TESTING (POCT) MARKET OVERVIEW

The point-of-care testing (poct) market value at USD 0.26 billion in 2025, and reaching USD 0.61 billion by 2034, expanding at a CAGR of 9.97% from 2025 to 2034.

The United States Point-Of-Care Testing (POCT) market size is projected at USD 0.082 billion in 2025, the Europe Point-Of-Care Testing (POCT) market size is projected at USD 0.062 billion in 2025, and the China Point-Of-Care Testing (POCT) market size is projected at USD 0.079 billion in 2025.

Point-Of-Care Testing (POCT) market is evolving extremely quickly with increasing demand for quick diagnosis results and increased focus on patient-centric care. POCT offers the possibility of diagnostic testing by clinical professionals at or near the patient's location, enabling quicker decision-making and treatment. The market is being fueled by increases in chronic diseases, infectious disease outbreak surges, and decentralized healthcare facility expansion. Technological advancements in miniaturized and networked devices are also enhancing the accuracy and accessibility of POCT solutions. Additionally, enhanced usage of POCT in the emerging markets is generating new business opportunities for manufacturers. In view of continued innovations and conducive regulatory environments, the POCT market will be able to maintain steady growth in the future.

KEY FINDINGS

COVID-19 IMPACT

Point-Of-Care Testing (POCT) market Had a Positive Effect Due to Increased Demand During COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels. 

The COVID-19 pandemic drastically affected the Point-Of-Care Testing (POCT) industry, leading to challenges as well as opportunities. The need for rapid testing products worldwide due to the pandemic fast-tracked the production and roll-out of POCT kits, especially to detect COVID-19 infections. The global healthcare system then transitioned towards decentralized testing at this point, which resulted in a surge of the use of rapid antigen and antibody tests at hospitals, clinics, airports, and even domestically. The companies soon increased manufacturing, resulting in quicker innovations and heightened awareness about POCT benefits. Regulatory agencies also granted emergency use authorizations, which hastened market access for many new diagnostic devices. Though disruption of supply and initial shortage did cause some problems, in the end there was more investment made in POCT infrastructure and becoming an increasingly indispensable part of future healthcare provision.

LATEST TRENDS

Rise of Home-Based and Connected POCT Solutions to Drive Market Growth

One of the most important trends influencing the Point-Of-Care Testing (POCT) market is the increasing home and network-based testing devices. With increasing focus on the personalization of care and convenience, patients are increasingly using self-testing devices that enable them to get fast and precise results without making visits to clinics. The trend is supported by the increasing smart devices and digital healthcare platforms that enable real-time data sharing with healthcare professionals. Integration with mobile applications is also enabling continuous monitoring and increased patient engagement. Firms are developing smaller, user-friendly devices for diabetes, infectious diseases, and cardiac health for home-based chronic illness management. Telemedicine growth is also aiding this shift, with remote diagnosis emerging as the requirement for proactive and preventive care. This technology-powered model of home-based diagnosis is transforming the diagnostics of the future.

• North America accounted for approximately 43.6 % of the global point-of-care diagnostics market in 2024.
• The infectious disease segment led the POCT diagnostics market with a share of 25.4 % in 2024.

Request a Free sample to learn more about this report

POINT-OF-CARE TESTING (POCT) MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Urinalysis Testing, Others:

• Blood Glucose Testing: Blood glucose testing constitutes one of the largest markets under POCT due to the great prevalence of diabetes worldwide. Glucose tests that deliver quick measurement of the concentration of glucose within the blood, enabling patients as well as professionals to titrate and manage care right away. Continuous glucose sensors and portable glucometers have facilitated it tremendously for patients to adhere. With development in technology, many devices are now synchronized with cell phone apps, giving trend analysis and remote consultation. The growing awareness for diabetic complications and the emphasis to monitor daily have made blood glucose testing a valuable tool in chronic disease management. With rising demand globally, manufacturers are resorting to cost-friendly and minimally invasive means of improvement to test experiences.

• Infectious Diseases Testing: Infectious disease screening by POCT has assumed vital significance, particularly following global outbreaks. POCT tests facilitate immediate detection of such pathogens as influenza, COVID-19, HIV, malaria, and others directly at the patient locations, with a possibility of immediate isolation or treatment as necessary. Increased antimicrobial resistance has also further emphasized the role of rapid diagnosis to inform appropriate treatment decisions. POCT instruments for infectious diseases are increasingly being adopted in hospitals, mobile health clinics, and even rural areas because they are portable and convenient to use. Advancements are directed towards multiplex testing, where multiple pathogens are detected simultaneously. This kind of POCT is playing an indispensable role in pandemic readiness and global health security strategies, and this sector is being further invested in and improved.

• Cardiac Markers Test: Cardiac markers testing in the POCT setting is essential for early detection and management of cardiovascular events, particularly heart attacks. The tests can measure critical biomarkers such as troponin, BNP, and CK-MB at the point of care so that emergency teams and clinicians can make quick decisions. The potential to diagnose acute cardiac conditions in minutes, not hours, has been lifesaving in the critical care environment. Demand for the tests is being fueled by growing incidence of heart disease and the pressure to accelerate triage in emergency rooms. Portable analyzers and handheld devices are also moving beyond hospital walls to ambulances and rural clinics. Ongoing advances in sensitivity and accuracy are also making them more valuable in the clinical setting.

• Coagulation Testing: Coagulation testing via POCT is ever more crucial for patients on anticoagulant therapy and those at risk of clotting disorders. Such tests, especially those that monitor parameters such as INR and PT, enable real-time medication adjustment, minimizing the risk of adverse effects such as bleeding or thrombosis. The ease of POCT for coagulation testing facilitates its use in both hospital and home care environments. Chronic cardiovascular patients or those post-surgeries gain much from this form of monitoring. Advances in portable coagulation analyzers have also boosted precision and usability, allowing them to be more used by non-specialist professionals. With increasingly patient-focused care models, POCT coagulation testing remains an integral part of targeted treatment strategies and post-discharge management.

• Pregnancy and Fertility Tests: Pregnancy and fertility testing is a large and mature POCT market segment with fast, convenient, and discreet solutions available. The assays enable women to test for pregnancy or monitor ovulation without necessarily visiting clinics. As the awareness for reproductive health increases, consumers are also using home-based fertility kits to monitor hormone shifts and tailor conception attempts. Producers have added digital enhancements to simple test strips, such as Bluetooth devices and smartphone apps for interpretation and monitoring of results. These innovations provide a more personalized experience and higher convenience. Increased access to pharmacies and online retailers has further boosted availability. As individuals place greater emphasis on anticipatory reproductive planning, demand for authentic, accurate, and technology-enabled testing continues to rise in developed and emerging markets.

• Blood Gas/Electrolytes Testing: Blood gas and electrolytes testing through POCT is an important aspect of critical and emergency care through the instant feedback of the respiratory and metabolic status of a patient. The tests are used to monitor oxygenation, ventilation, and acid-base balance, which are essential in the care of patients with illnesses such as sepsis, chronic obstructive pulmonary disease, and renal impairment. The ability to perform such tests bedside is especially useful in intensive care, operating rooms, and ambulances. Current POCT analyzers offer miniature size, low turnaround time, and onboard computer management, thus enhancing clinical effectiveness. With high demand for expeditious critical care, the utility of blood gas and electrolyte POCT instruments increases more in situations requiring speedy decision-making. Their use is also increasing in decentralized and rural health care environments.

• Urinalysis Testing: Urinalysis testing in the POCT market is an easy-to-use diagnostic device for a wide variety of conditions such as urinary tract infections, kidney disease, and metabolic disease. The tests are fast and non-invasive, making them ideal for regular check-ups and initial diagnosis. POCT urinalysis kits are used extensively in primary care, emergency departments, and at home because they are convenient and easy to interpret. Present-day innovation has brought electronic readers and smartphone connectivity, reduced human error and improved data capture. Increased emphasis on preventive care and disease detection at an earlier stage is driving demand for convenient POCT urinalysis products. With healthcare evolving into more individualized and decentralized systems, convenience and ease of accessibility are keeping these tests on a steady growth path.

By Application

Based on application, the global market can be categorized into Hospitals, Clinic, Laboratory, Others:

• Hospitals: Hospitals are one of the principal areas where POCT is used because emergency and critical care conditions need immediate diagnostic information. These tests provide physicians with rapid assessment of a patient's condition and make real-time clinical decisions, especially in emergency rooms, ICUs, and operating suites. POCT increases patient benefits and operational efficiency by shortening the time to test and treat. All hospitals now link POCT with electronic health records, streamlining work processes and reducing delays. Even more significant, growing pressure on the hospital to shorten turnaround time and reduce hospital stay is accelerating the adoption of POCT. Inpatient monitoring and bedside diagnosis through POCT are becoming the standard of care in modern hospitals.

• Clinic: Clinics are quickly embracing POCT technologies as they can provide instant diagnostic data, thereby improving outpatient care quality. Clinics have walk-in or time-dependent patients daily, and hence instantaneous diagnostic devices are essential for efficient triage and therapy. POCT devices used in clinics include blood glucose meters and urinalysis sticks for tests for infectious diseases and cardiac markers. Their compact nature, ease of use, and absence of a need for comprehensive training requirements make them immensely appropriate for specialists and generalists as well. POCT similarly benefits clinics by alleviating the requirement for follow-up visits or referrals to laboratories, thus enhancing patient satisfaction and clinic workflow burdens. As convenience and effectiveness become increasingly emphasized in primary care, POCT is emerging as a core element of contemporary clinical practice.

• Laboratory: Even as conventionally they are dominated by centralized configurations, labs are presently integrating POCT machines to boost their diagnostic power. Such systems prove most helpful when handling big volumes of patients or in obtaining prompt preliminary reports before complete laboratory examination. With POCT, decentralized or satellite laboratories enhance their diagnostic turnaround time and remove organizational hurdles. Modern POCT analyzers currently offer near-laboratory accuracy, making them a value for emergency screenings or preliminary assessment. Laboratories also utilize POCT to offer support to outreach programs and mobile testing facilities, especially in rural or underprivileged areas. Moreover, the integration of digital platforms makes it possible for laboratories to analyze POCT information in addition to conventional test information. As laboratories want greater flexibility and faster processing, POCT is increasingly becoming a strategic offshoot of their activities.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

Rising Demand for Rapid Diagnostics and Decentralized Healthcare to Boost the Market 

Increased focus on earlier diagnosis and quicker decision-making for treatment is leading mainly to the acceptance of Point-Of-Care Testing (POCT) market growth solutions. Doctors and patients want machines to give instant results without referring the samples to the central labs. There is special demand in emergency units, outstation areas, and developing countries where lab setups are not always available. POCT enables faster clinical decision-making, reduced patient waiting times, and higher overall quality of care. As the delivery of healthcare continues to shift toward home and outpatient-based models, easy and decentralized testing remains on the rise. The shift is forcing manufacturers to come up with more compact, convenient, and very reliable POCT products that solve evolving clinical work processes and patient demands.

• A rising number of approved diagnostic devices has strengthened POCT adoption, especially in clinical settings, contributing to more than 40 % usage across decentralized healthcare facilities.
• The global burden of chronic and infectious diseases is accelerating POCT adoption, with more than 60 % of demand linked to diabetes, cardiovascular, and infectious disease management.

Technological Advancements in Diagnostic Devices to Expand the Market

Technological advancements in microfluidics, biosensors, miniaturization, and connectivity are revolutionizing the face of point-of-care diagnostics. New POCT devices are now more intelligent, quicker, and easier to use, enabling both clinicians and patients to conduct precise tests with reduced training. Connectivity options such as Bluetooth and cloud-based systems facilitate easy transfer of data to electronic health records and remote monitoring systems. These technologies are also minimizing errors and enhancing uniformity in test outcomes. Moreover, AI-driven analytics and multi-analyte detection functionality are being incorporated to enable more advanced health evaluations. Therefore, the growing technological complexity of POCT devices is making them more useful, reliable, and desirable in diverse segments of healthcare.

Restraining Factor

Concerns Over Accuracy and Quality Control in Non-Laboratory Settings to Potentially Impede Market Growth

Although they are convenient, POCT devices have traditionally been questioned in terms of consistency and accuracy when used outside their usual laboratory environment. In clinical laboratories, testing is performed under strict quality control by trained operators. However, in decentralized or home settings, test results can be invalidated by misuse, user error, or device variability. These can lead to misdiagnosis or delayed decision to treat, potentially compromising patient safety. Moreover, there are some medical professionals who are still hesitant to adopt POCT due to calibration, maintenance, and data merging into medical reports fears. Global adoption is complicated due to varying POCT standards for regulation as well. Those are the complications still serving as a barrier toward general acceptance in every healthcare sector.

• POCT currently represents less than 15% of the in-vitro diagnostic (IVD) market, while routine laboratory testing still accounts for around 45%.
• More than 30% of POCT users report concerns about inconsistent accuracy and lack of standardization, which restrains wider adoption.

Expansion of POCT in Emerging Markets and Rural Healthcare to Create Opportunity for The Product in The Market

Opportunity

The most likely direction for the POCT market is its growth in developing countries and rural remote locations. Centralized laboratories and advanced medical facilities are beyond the reach of most of them. POCT products offer a pragmatic solution by enabling faster on-site diagnosis without advanced installations or experts. Governments and international health organizations are increasingly backing projects deploying POCT for screening disease, maternal health, and managing chronic diseases in low-resource areas. Also, rising healthcare consciousness and proliferation of mobile health centers are speeding the use of POCT in distant communities. As companies design lower-cost, robust, and simpler devices, the scope to close diagnostic gaps in these areas increases tremendously.

• Decentralized POCT models enable healthcare providers to deliver testing closer to patients, helping to reduce care costs by nearly 20% compared with hospital-based diagnostics.
• During the COVID-19 pandemic, POCT use increased by over 50%, proving its critical role in rapid disease management and opening pathways for expansion into other therapeutic areas.

Integration of POCT Results into Centralized Healthcare Systems Could Be a Potential Challenge for Consumers

Challenge

One of the central challenges for the POCT industry is the lack of seamless inclusion of test data in centralized health systems and electronic medical records. As POCT is applied to more diverse venues—homes, ambulances, and clinics—the consistency and security of transmission of data in a standardized system become complicated. Diverse instruments and software environments are typically unstandardized and thus interoperability becomes a difficult barrier. Healthcare practitioners require timely access to diagnostic results for continuity of care, while dispersed data risk delaying or falsifying clinical decisions. Moreover, IT infrastructure across most institutions can be incapable of handling the burgeoning amount and type of data associated with POCT. Overcoming this is a key to ensuring the full benefits of POCT value in healthcare ecosystems that are interconnected.

• In field evaluations, over 25% of POCT devices demonstrated variability compared to centralized laboratory results, creating challenges for clinical acceptance.
• More than 35% of healthcare providers highlight cost and training needs as barriers to integrating POCT devices into regular workflows.

POINT-OF-CARE TESTING (POCT) MARKET REGIONAL INSIGHTS

• Request a Free sample to learn more about this report

•  

• North America

North America, and the United States Point-Of-Care Testing (POCT) market in particular, has a stranglehold on the POCT market due to strong healthcare centers, advanced technologies, and high incidence of chronic diseases. The United States has adopted POCT in hospitals, urgent care centers, and homecare at a rapid rate, driven by the need for speedy diagnosis and better patient care. Government endorsement, healthcare reimbursement policies, and increased consumer education have also spurred the market. The region is also leading in embracing POCT through digital platforms to enable seamless sharing of data as well as remote monitoring. Besides, the concentration of market players, ongoing R&D, as well as periodic product releases, all attribute to the dominance of the region within the global POCT landscape.

• Europe

Europe enjoys a large market share in POCT due to the developed healthcare infrastructure and greater emphasis on preventive medicine. Major nations such as Germany, the UK, and France are among the leading nations which have been focusing on POCT solutions in geriatric centers, clinics, and hospitals to drive diagnosis time and patient outcomes. To grow decentralized testing, especially in the wake of the COVID-19 pandemic that fueled decentralized testing, Europe is experiencing rising demand for screening infectious diseases. There is also growth in regulatory incentives and funding and the deployment of emerging diagnostic technology. In addition to that, the age-old demographic in Europe is stimulating the demand for chronic illness management solutions like use-at-home POCT equipment. This is compelling manufacturers to make more converged and tailored test solutions tailored directly to regional health demands.

• Asia

Asia is becoming one of the most rapidly growing markets for POCT, driven by increased healthcare awareness, population growth, and expanding rates of chronic and infectious diseases. China, India, and Japan are all experiencing high uptake of POCT devices in hospitals, community clinics, and mobile health units. The area's drive to enhance rural access to healthcare has prompted POCT to become a viable solution with its portability and low infrastructure demands. Government efforts to support diagnostic outreach, as well as the availability of local manufacturing, are further driving market expansion. The growing middle class and need for convenient home diagnosis are also stimulating innovation in affordable, user-friendly POCT devices suited to the region's varied healthcare settings

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

Market leaders in the POCT marketplace are driving innovation and growth head-on in order to address increasing global demand. The large marketplace companies are committed to creating smaller, faster, and easier diagnostic devices that integrate into a variety of care settings. Digital connectivity is being paid attention to, which will support real-time transfer of results and distant monitoring. Numerous firms are building out product lines via acquisitions and partnerships focused on wider diagnostic categories such as infectious disease, cardiology, and chronic disease management. Others are making significant investments in R&D to make their testing platforms more sensitive and accurate. Others are addressing manufacturing scaling and global distribution, particularly in the developing world. Taken together, these initiatives are creating a fast-changing and very competitive POCT environment.

• Menarini Diagnostics: Menarini has specialized in blood-glucose self-testing systems for diabetes since 1976, maintaining a strong presence in the European POCT market.
• Johnson & Johnson: Johnson & Johnson contributes significantly to global POCT adoption, with its diagnostic segment accounting for more than 10 % of the company’s healthcare product portfolio.

List Of Top Point-Of-Care Testing (Poct) Market Companies

• A. Menarini Diagnostics
• Johnson & Johnson
• Trinity Biotech
• Princeton BioMeditech
• Quidel
• Helena Laboratories
• Trividia Health
• Chembio Diagnostics
• Nova Biomedical
• Bio-Rad Laboratories
• ARKRAY
• Accriva
• Siemens Healthcare
• Roche
• Phamatech
• Ortho Clinical Diagnostics
• OraSure Technologies
• Ascensia
• Abaxis (Zoetis)
• Danaher
• ELITech Group
• Alfa Wassermann
• Response Biomedical
• BioMerieux
• Abbott

KEY INDUSTRY DEVELOPMENT

February 2025: A milestone moment for the Point-Of-Care Testing (POCT) market came in the form of FDA clearance for the first home over-the-counter dual test for influenza and COVID-19. This home-test product lets the consumer conduct a self-diagnostics at home with fast return on results for both ailments. It represents an enormous breakthrough towards unleashing more capabilities for POCT into regular health care, particularly the administration of respiratory illness management. It also demonstrates increasing regulatory backing for diagnostics accessible to consumers. This initiative is likely to drive innovation within multi-analyte testing and solidify incorporation of POCT solutions into conventional and home-care environments.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis considers both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.
The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.